Therapeutic Targets in Osteosarcoma

Advantages

1. Targeting ion channels that are highly expressed on osteosarcoma cells
2. Enables development using an original and highly sensitive screening system

Background and Technology

Using a unique model of osteosarcoma cancer stem cells, the inventors found that increased expression of a certain conductance calcium-activated potassium (KCa) channel plays an important role in the mechanism of differentiation and malignant transformation of osteosarcoma cancer stem cells.

Data and Publication

We transplanted osteosarcoma carcinoma cells into the femur of mice and examined the expression of the KCa channel mRNA in tumor tissues, and found that the KCa channel mRNA was highly expressed in primary (intramedullary cell transplantation) and metastatic (lung) tissues

Expectation

Searching for a company to collaborate on drug development for osteosarcoma drugs using a proprietary, highly sensitive screening model.

Product No. WL-03044

Medicine

Published

Inquiry Form

Your Name (*Required)

E-Mail Address (*Required)

Company Name

Message

Following submission of your inquiry

We will contact you shortly to discuss confidentiality, materials transfer, evaluation steps, and licensing opportunities.

<Notice>

Our support is provided free of charge.
The information submitted on this form is for business development use only.

About Bionauts.jp Tech Manage Corp.
Copyright © Tech Manage Corp. All Rights Reserved.